Skip to main content

Loading market data...

PODD

Insulet Corporation

NASDAQ • United states

$141.90

-$0.74

(-0.52%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:00 GMT+0000

Management
Credibility
Score

Insulet Corporation (PODD)

Unavailable

Quotes may be delayed

$9.84B

Market Cap

1,044,937

Volume

26.2

P/E Ratio

Unavailable

Div Yield

Insulet Corporation Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 100 NAGOG PARK, ACTON, MA
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

22 Sep 2026

Insulet Corporation reported A material agreement

Insulet Corporation filed an 8-K covering a material agreement, a material financing obligation, supporting financial statements or exhibits.

17 Sep 2026

Insulet Corporation reported A director or senior management change or compensation event

Insulet Corporation filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.

11 Sep 2026

Insulet Corporation reported A director or senior management change or compensation event

Insulet Corporation filed an 8-K covering a director or senior management change or compensation event.

6 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Insulet Corporation.

6 Aug 2026

Insulet Corporation filed Form 10-Q

Insulet Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$856.60M

Total assets (USD)$3.17B

Total liabilities (USD)$1.74B

Shareholders' equity (USD)$1.42B

Long-term debt (USD)$1.37B

Debt due within a year (USD)$18.90M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$801.70M	$129.70M	$95.00M	$1.37	10-Q · 5 Aug 2026
Q1 2026	$761.70M	$122.10M	$91.10M	$1.30	10-Q · 6 May 2026
Q4 2025	$783.80M	$146.30M	$101.60M	Unavailable	10-K · 18 Feb 2026
Q3 2025	$706.30M	$117.70M	$87.60M	$1.24	10-Q · 6 Nov 2025
Q2 2025	$649.10M	$121.10M	$22.50M	$0.32	10-Q · 7 Aug 2025
Q1 2025	$569.00M	$88.80M	$35.40M	$0.50	10-Q · 9 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $164.12

15.7% upside potential

📈

Strong Buy

Unavailable

👍

Buy

10

⏸️

Hold

10

📉

Sell

0

20 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 22 Oct 2026, 05:48 UTC Targets range 143.00–190.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

1

Oct 2026

Pease Flavia

EVP & CFO

Tax withholding

$130.79 per share

1,882 shares

30

Sep 2026

MAZELSKY JONATHAN JAY

Director

Grant or award

$130.47 per share

141 shares

30

Sep 2026

Huffines Robert Luther

Director

Grant or award

$130.47 per share

178 shares

21

Aug 2026

McEvoy Ashley

Director, President and CEO

Open-market purchase

$147.47 per share

1,100 shares

1

Aug 2026

Davis Lisa Blair

SVP, Chief HR Officer

Tax withholding

$165.35 per share

244 shares

1

Jul 2026

MAZELSKY JONATHAN JAY

Director

Grant or award

Unavailable per share

1,355 shares

30

Jun 2026

Huffines Robert Luther

Director

Grant or award

$152.25 per share

151 shares

30

Jun 2026

Huffines Robert Luther

Director

Grant or award

$159.79 per share

144 shares

Top Shareholders

Vanguard Group Inc

8,701,472 shares

-1.077% change

12/31/2025

Blackrock, Inc.

6,690,192 shares

4.929% change

6/30/2026

Vanguard Capital Management Llc

4,525,333 shares

-1.178% change

6/30/2026

State Street Corp

3,197,555 shares

5.098% change

6/30/2026

Vanguard Portfolio Management Llc

3,075,932 shares

-10.842% change

6/30/2026

Aqr Capital Management Llc

2,455,135 shares

53.568% change

6/30/2026

Baillie Gifford & Co

2,042,313 shares

0.632% change

6/30/2026

Geode Capital Management, Llc

2,003,861 shares

-1.078% change

6/30/2026

Two Sigma Investments, Lp

1,903,734 shares

149.719% change

6/30/2026

Invesco Ltd.

1,694,651 shares

54.546% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 22 Oct 2026, 05:49 UTC· 4 hours ago

Research coverage and investment tools

Insulet Corporation (PODD) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Medical/Dental Instruments). Its last price was US$141.90 on 21 Oct 2026. That is 7% of the way from its 52-week low of US$126.40 to its 52-week high of US$354.88. Its market capitalisation was US$9.84 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$801.70M	$129.70M	$95.00M	$1.37	70.2%	16.2%	$55.90M	10-Q · 5 Aug 2026 (opens in a new tab)
Q1 2026	$761.70M	$122.10M	$91.10M	$1.30	69.5%	16.0%	$89.50M	10-Q · 6 May 2026 (opens in a new tab)
Q4 2025	$783.80M	$146.30M	$101.60M	Unavailable	72.5%	18.7%	$48.20M	10-K · 18 Feb 2026 (opens in a new tab)
Q3 2025	$706.30M	$117.70M	$87.60M	$1.24	72.2%	16.7%	$100.10M	10-Q · 6 Nov 2025 (opens in a new tab)
Q2 2025	$649.10M	$121.10M	$22.50M	$0.32	69.7%	18.7%	$177.90M	10-Q · 7 Aug 2025 (opens in a new tab)
Q1 2025	$569.00M	$88.80M	$35.40M	$0.50	71.9%	15.6%	$51.50M	10-Q · 9 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	8/5/2026	$1.66	$1.44	+15.3%
Mar 2026	5/6/2026	$1.42	$1.14	+24.6%
Dec 2025	2/18/2026	$1.55	$1.48	+4.7%
Sep 2025	11/6/2025	$1.24	$1.13	+9.7%

Cash and equivalents: $856.60M
Total assets: $3.17B
Total liabilities: $1.74B
Shareholders' equity: $1.42B
Long-term debt: $1.37B
Debt due within a year: $18.90M

8-K · 22 Sep 2026 · Material agreement Signed

Insulet Corporation reported A material agreement (opens in a new tab)

Insulet Corporation filed an 8-K covering a material agreement, a material financing obligation, supporting financial statements or exhibits.
8-K · 17 Sep 2026 · Management change

Insulet Corporation reported A director or senior management change or compensation event (opens in a new tab)

Insulet Corporation filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.
8-K · 11 Sep 2026 · Management change

Insulet Corporation reported A director or senior management change or compensation event (opens in a new tab)

Insulet Corporation filed an 8-K covering a director or senior management change or compensation event.
SCHEDULE 13G/A · 6 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Insulet Corporation.
10-Q · 6 Aug 2026

Insulet Corporation filed Form 10-Q (opens in a new tab)

Insulet Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

Insider	Date	Transaction	Shares	Average price	Filing
Pease Flavia EVP & CFO	1 Oct 2026	Tax withholding (F)	−1,882	$130.79	Form 4 (opens in a new tab)
MAZELSKY JONATHAN JAY Director	30 Sep 2026	Grant or award (A)	+141	$130.47	Form 4 (opens in a new tab)
Huffines Robert Luther Director	30 Sep 2026	Grant or award (A)	+178	$130.47	Form 4 (opens in a new tab)
McEvoy Ashley Director, President and CEO	21 Aug 2026	Open-market purchase (P)	+1,100	$147.47	Form 4 (opens in a new tab)
Davis Lisa Blair SVP, Chief HR Officer	1 Aug 2026	Tax withholding (F)	−244	$165.35	Form 4 (opens in a new tab)
MAZELSKY JONATHAN JAY Director	1 Jul 2026	Grant or award (A)	+1,355	—	Form 4 (opens in a new tab)
Huffines Robert Luther Director	30 Jun 2026	Grant or award (A)	+151	$152.25	Form 4 (opens in a new tab)
Huffines Robert Luther Director	30 Jun 2026	Grant or award (A)	+144	$159.79	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	8,701,472	-1.077%
Blackrock, Inc.	6/30/2026	6,690,192	4.929%
Vanguard Capital Management Llc	6/30/2026	4,525,333	-1.178%
State Street Corp	6/30/2026	3,197,555	5.098%
Vanguard Portfolio Management Llc	6/30/2026	3,075,932	-10.842%
Aqr Capital Management Llc	6/30/2026	2,455,135	53.568%
Baillie Gifford & Co	6/30/2026	2,042,313	0.632%
Geode Capital Management, Llc	6/30/2026	2,003,861	-1.078%
Two Sigma Investments, Lp	6/30/2026	1,903,734	149.719%
Invesco Ltd.	6/30/2026	1,694,651	54.546%

Previous close: 142.64 USD
Day range: 140.81 – 146.63 USD
52-week range: 126.40 – 354.88 USD
Volume: 1,044,937
Market cap: $9.84B
Average volume: 1,632,079
P/E ratio: 26.2
EPS (FY 2025, diluted): 3.48 USD
Shares outstanding: 69.35M
Beta (5Y monthly): 1.08

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:00 UTC· 14 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 08:09 UTC· 2 hours ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for PODD yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.